These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 34583196)
1. Establishment of a novel monoclonal antibody against truncated glycoforms of α-dystroglycan lacking matriglycans. Yamasaki F; Umezawa F; Sensui T; Anzo M; Abo H; Kuo CW; Khoo KH; Kato K; Yagi H; Kawashima H Biochem Biophys Res Commun; 2021 Nov; 579():8-14. PubMed ID: 34583196 [TBL] [Abstract][Full Text] [Related]
2. CDP-glycerol inhibits the synthesis of the functional Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773 [TBL] [Abstract][Full Text] [Related]
3. PCYT2 synthesizes CDP-glycerol in mammals and reduced PCYT2 enhances the expression of functionally glycosylated α-dystroglycan. Imae R; Manya H; Tsumoto H; Miura Y; Endo T J Biochem; 2021 Oct; 170(2):183-194. PubMed ID: 34255834 [TBL] [Abstract][Full Text] [Related]
4. Biosynthetic Mechanisms and Biological Significance of Glycerol Phosphate-Containing Glycan in Mammals. Imae R; Manya H; Endo T Molecules; 2021 Nov; 26(21):. PubMed ID: 34771084 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory machinery for the functional dystroglycan glycosylation. Kondo Y; Okajima T J Biochem; 2023 Apr; 173(5):333-335. PubMed ID: 36760122 [TBL] [Abstract][Full Text] [Related]
6. Cancer Malignancy Is Correlated with Upregulation of PCYT2-Mediated Glycerol Phosphate Modification of α-Dystroglycan. Umezawa F; Natsume M; Fukusada S; Nakajima K; Yamasaki F; Kawashima H; Kuo CW; Khoo KH; Shimura T; Yagi H; Kato K Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743105 [TBL] [Abstract][Full Text] [Related]
7. Chemical and Chemo-Enzymatic Syntheses of Glycans Containing Ribitol Phosphate Scaffolding of Matriglycan. Tamura JI; Tamura T; Hoshino S; Imae R; Kato R; Yokono M; Nagase M; Ohno S; Manabe N; Yamaguchi Y; Manya H; Endo T ACS Chem Biol; 2022 Jun; 17(6):1513-1523. PubMed ID: 35670527 [TBL] [Abstract][Full Text] [Related]
8. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding. Patnaik SK; Stanley P J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414 [TBL] [Abstract][Full Text] [Related]
9. Direct Mapping of Additional Modifications on Phosphorylated O-glycans of α-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy. Yagi H; Kuo CW; Obayashi T; Ninagawa S; Khoo KH; Kato K Mol Cell Proteomics; 2016 Nov; 15(11):3424-3434. PubMed ID: 27601598 [TBL] [Abstract][Full Text] [Related]
11. Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammals. Hoshino S; Manya H; Imae R; Kobayashi K; Kanagawa M; Endo T J Biochem; 2024 Mar; 175(4):418-425. PubMed ID: 38140954 [TBL] [Abstract][Full Text] [Related]
12. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase. Zhang P; Hu H Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648 [TBL] [Abstract][Full Text] [Related]
13. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition. Praissman JL; Willer T; Sheikh MO; Toi A; Chitayat D; Lin YY; Lee H; Stalnaker SH; Wang S; Prabhakar PK; Nelson SF; Stemple DL; Moore SA; Moremen KW; Campbell KP; Wells L Elife; 2016 Apr; 5():. PubMed ID: 27130732 [TBL] [Abstract][Full Text] [Related]
14. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan. Manya H; Endo T Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406 [TBL] [Abstract][Full Text] [Related]
15. Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth. Lu PJ; Tucker JD; Branch EK; Guo F; Blaeser AR; Lu QL Sci Rep; 2020 Mar; 10(1):4935. PubMed ID: 32188898 [TBL] [Abstract][Full Text] [Related]
16. Exploring the In situ pairing of human galectins toward synthetic O-mannosylated core M1 glycopeptides of α-dystroglycan. Villones LL; Ludwig AK; Kumeta H; Kikuchi S; Ochi R; Aizawa T; Nishimura SI; Gabius HJ; Hinou H Sci Rep; 2022 Oct; 12(1):17800. PubMed ID: 36274065 [TBL] [Abstract][Full Text] [Related]
17. Glycoproteomic characterization of recombinant mouse α-dystroglycan. Harrison R; Hitchen PG; Panico M; Morris HR; Mekhaiel D; Pleass RJ; Dell A; Hewitt JE; Haslam SM Glycobiology; 2012 May; 22(5):662-75. PubMed ID: 22241827 [TBL] [Abstract][Full Text] [Related]
18. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan. Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719 [TBL] [Abstract][Full Text] [Related]
19. Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle. Stalnaker SH; Hashmi S; Lim JM; Aoki K; Porterfield M; Gutierrez-Sanchez G; Wheeler J; Ervasti JM; Bergmann C; Tiemeyer M; Wells L J Biol Chem; 2010 Aug; 285(32):24882-91. PubMed ID: 20507986 [TBL] [Abstract][Full Text] [Related]
20. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]